Larson Financial Group’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23
Closed -$7.49K 2509
2024
Q1
$7.49K Hold
23
﹤0.01% 1113
2023
Q4
$4.38K Sell
23
-6
-21% -$1.13K ﹤0.01% 1213
2023
Q3
$5.77K Buy
29
+6
+26% +$1.42K ﹤0.01% 1133
2023
Q2
$6.56K Hold
23
﹤0.01% 1044
2023
Q1
$4.99K Hold
23
﹤0.01% 1088
2022
Q4
$4.73K Hold
23
﹤0.01% 1043
2022
Q3
$6K Hold
23
﹤0.01% 936
2022
Q2
$4K Hold
23
﹤0.01% 928
2022
Q1
$5K Hold
23
﹤0.01% 801
2021
Q4
$4K Hold
23
﹤0.01% 879
2021
Q3
$5K Hold
23
﹤0.01% 703
2021
Q2
$4K Hold
23
﹤0.01% 667
2021
Q1
$3K Hold
23
﹤0.01% 689
2020
Q4
$2K Hold
23
﹤0.01% 661
2020
Q3
$2K Hold
23
﹤0.01% 623
2020
Q2
$1K Buy
+23
New +$948 ﹤0.01% 665

Other funds holding SWAV

Larson Financial Group's SWAV Position: Q2 2024 in Review

Larson Financial Group sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 23 shares — an estimated $7.49K sold.

Larson Financial Group first reported a position in SWAV in Q2 2020 and held it in 16 quarters. The position peaked at $7.49K in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Larson Financial Group reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Larson Financial Group sold 23 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $7.49K.
  • Larson Financial Group first reported a position in Shockwave Medical, Inc. Common Stock in Q2 2020 and held it in 16 quarters.
  • Larson Financial Group's Shockwave Medical, Inc. Common Stock position peaked at $7.49K in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Larson Financial Group's 13F filing for Q2 2024, filed 2 Aug 2024.